In October 2015 SoniVie won first prize in the innovative companies' competition at the TCT 2015 - most meaningful interventional cardiology conference held in the United States.

About SoniVie:


SoniVie is a medical device company developing a system for the treatment of pulmonary hypertension. PH is an incurable disease that affects millions of people in the US and Europe. The company's scientific advisory board comprises worldwide leading experts in the fields of Pulmonary Hypertension and Cardiology; The Company's medical director is Dr. Martin Leon from the Center for Interventional Vascular Therapy Columbia University Medical Center / New York-Presbyterian Hospital, a cardiologist who is considered the world's most influential interventional cardiologist. The company's offices are located in Rosh-Haayin, Israel.

About Accelmed:

Accelmed is the largest pure play medical device fund in Israel. Accelmed focuses on global investments in mature companies that might serve as a platform to Israeli companies and also builds companies that develop innovative medical devices solutions for major markets such as diabetes, obesity and heart diseases, in which there is currently no medical solution. Since it was founded in 2009 by Mori Arkin, the chairman of the investment committee, and Dr. Uri Geiger, the managing partner, the firm has made 18 investments in medical device companies, including M&A and IPO of five of them. Existing companies in the portfolio include Valcare, EndoSpan, SoniVie, CartiHeal, Nitiloop, Digma, Memic, and NitiNotes.

Accelmed has a large and experienced investment management team which other than Dr Uri Geiger and Mori Arkin, includes four additional partners (Dr. Irit Yaniv, Ilan Ben Oren, Lior Shav, and Amir Blatt) together with a team of analysts and well-known advisors.

More information can be found in Accelmed's website: http://www.accelmed.com


SOURCE Accelmed

Back to HCB News

Products and Clearances Homepage